Your browser doesn't support javascript.
loading
Safety and Efficacy of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Cancer.
Wang, Bin; Dong, Yang; Yu, Xuyao; Li, Fengtong; Wang, Jingsheng; Chen, Huaming; Niu, Zeqian; Song, Yongchun; Yuan, Zhiyong; Tao, Zhen.
Afiliación
  • Wang B; Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Dong Y; Department of Radiation Oncology, CyberKnife Center and Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Yu X; Department of Radiation Oncology, CyberKnife Center and Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Li F; Department of Radiation Oncology, CyberKnife Center and Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Wang J; Department of Radiation Oncology, CyberKnife Center and Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Chen H; Department of Radiation Oncology, CyberKnife Center and Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Niu Z; Department of Radiation Oncology, CyberKnife Center and Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Song Y; Department of Radiation Oncology, CyberKnife Center and Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Yuan Z; Department of Radiation Oncology, CyberKnife Center and Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Tao Z; Department of Radiation Oncology, CyberKnife Center and Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Front Oncol ; 12: 868844, 2022.
Article en En | MEDLINE | ID: mdl-35600391
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza